By G HossainPosted on August 8, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs In December 2024, Dewpoint Therapeutics CEO Ameet Nathwani said the biotech’s cash runway would last until the third quarter of 2025. Dewpoint Slashes Headcount by 70% as Cash Runway Runs Out Post navigation Gilead Confident in PrEP Franchise Even Amid Preventive Task Force UncertaintiesBicycle, Tune, Iovance, Precision Downsize to Conserve Cash